Thorsten Degenhardt,Robert Schotzinger,J. Wesley Fox
申请号：
US13935791
公开号：
US20130295074A1
申请日:
2013.07.05
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention provides pharmaceutical compositions comprising dosage units of pyridoxamine, or a pharmaceutically acceptable salt thereof； and a pharmaceutically acceptable carrier, and methods for their use in limiting the progression of renal disease and/or diabetic complications in human diabetic patient.
